{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021302","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.402620+00:00","generated_at":"2026-06-01T01:34:21.757231+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Avenue Therapeutics stockholders approve 5M share increase to 2015 Incentive Plan","bullets":["Stockholders approved amendment to 2015 Incentive Plan, increasing authorized shares by 5,000,000.","Plan term extended to June 24, 2034; non-employee director annual limit increased to 500,000 shares.","All six director nominees elected; KPMG ratified as auditor for FY2024.","Total shares reserved under the plan after amendment: 5,070,223."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021302","json":"https://secwatch.observer/filing/0001437749-24-021302.json","markdown":"https://secwatch.observer/filing/0001437749-24-021302.md","text":"https://secwatch.observer/filing/0001437749-24-021302.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/0001437749-24-021302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/atxi20240625_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:34:21.757231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}